Document is current
Any future updates will be listed below
-
Authors
Gambril, John Alan https://orcid.org/0000-0001-9797-5979
Ghazi, Sanam M.
Sansoterra, Stephen https://orcid.org/0000-0002-8453-387X
Ferdousi, Mussammat
Kola-Kehinde, Onaopepo
Ruz, Patrick
Kittai, Adam S. https://orcid.org/0000-0002-4891-6144
Rogers, Kerry
Grever, Michael https://orcid.org/0000-0002-1605-7875
Bhat, Seema
Wiczer, Tracy
Byrd, John C. https://orcid.org/0000-0002-8778-1000
Woyach, Jennifer https://orcid.org/0000-0002-3403-9144
Addison, Daniel
-
Funding
Funding for this research was provided by:
Conquer Cancer, American Society of Clinical Oncology Career Development Award
Leukemia and Lymphoma Society (CDP 2331-20, CDP 2331-20)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01-CA197870, R35-CA197734, K12-CA133250, R01HL170038, K23-CA178183, R01-CA197870, R01HL170038, K23-HL155890, R01HL170038, R01HL1168045)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
Leukemia and Lymphoma Society
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
Robert Wood Johnson Foundation (Harold Amos) - American Heart Association Program Grant D. Warren Brown Foundation Four Winds Foundation Connie Brown CLL Foundation
- License Information
-
More Information
Article History
Received: 30 December 2023
Revised: 21 June 2024
Accepted: 1 July 2024
First Online: 17 August 2024
Competing interests
: This work was supported in part by National Institutes of Health (NIH)/ National Cancer Institute (NCI) grants K23-CA178183 (Woyach) and R01-CA197870 (Byrd and Woyach), R35-CA197734 (Byrd), K12-CA133250 (Byrd), K23-HL155890 (Addison), R01HL168045 (Addison), and R01HL170038 (Addison, Byrd, Woyach). Rogers and Woyach were supported by scholar in clinical research grants from the Leukemia & Lymphoma Society (CDP 2331-20). Kittai is a recipient of the Conquer Cancer, the American Society of Clinical Oncology (ASCO) Foundation Career Development Award. Addison was also supported by a Robert Wood Johnson Foundation (Harold Amos)- American Heart Association Program grant. Support also received from the D. Warren Brown Foundation, and Four Winds Foundations, and the Connie Brown CLL Foundation. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
: This work was approved by the Ohio State University Institutional Review Board (reference numbers 2018C0096 and 2019C0171) and is in alignment with the Declaration of Helsinki. Informed consent was obtained from all subjects.
